Top

Published in:

01-03-2003 | Editorial

Acinetobacter baumannii: a threat for the ICU?

Authors: Jordi Rello, Emili Diaz

Published in: Intensive Care Medicine | Issue 3/2003

Excerpt

In 1993, Fagon et al. [1] reported that when pneumonia was caused by Pseudomonas aeruginosa or Acinetobacter spp., the related mortality was estimated as high as 40%, with a relative risk of death of 2.50. This report was important by drawing attention to leading nosocomial pathogens and their association with mortality. However, it ignores the fact that the risk factors [2] and virulence factors [3] for both bacteria are completely different. Unfortunately, no matched cohort studies on pneumonia caused by A. baumannii as a single pathogen have been reported to ascertain its mortality. …

Fagon JY, Chastre J, Hance AJ, Montravers P, Novava A, Gibert C (1993) Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 94:281–288PubMed

Baraibar J, Correa H, Mariscal D, Gallego M, Valles J, Rello J (1997) Risk Factors for Infection by Acinetobacter Baumannii in intubated Patients With Nosocomial Pneumonia. Chest 112:1050–1054

Hauser AR, Cobb E, Bodi M, Mariscal D, Valles J, Engel JN, Rello J (2002) Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 30:521–528PubMed

Kollef MH, Ward S (1998) The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 113:412–420PubMed

Rello J, Gallego M, Mariscal D, Soñora R, Valles J (1997) The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 156:196–200

Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, Mariano N, Marks S, Burns JM, Dominick D, Lim M (1998) Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280:1233–1237PubMed

Corbella X, Montero A, Pujol M, Dominguez MA, Ayats J, Argerich MJ, Garrigosa F, Ariza J, Gudiol F (2000) Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 38:4086–4095PubMed

Husni RN, Goldstein LS, Arroliga AC, Hall GS, Fatica C, Stoller JK, Gordon SM (1999) Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients Chest 115:1378–1382

Rello J (1999) Acinetobacter baumannii infections in the ICU: customization is the key. Chest 115:1226–1229PubMed

10.

Freeman J, Mc Gowan JE Jr (1978) Risk factors for nosocomial infection. J infect Dis 138:811–819PubMed

11.

Blot S, Vandewoude K, Colardyn F (2003) Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med DOI 10.1007/s00134-003-1648-8

12.

Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Monterrubio-Villar J, Gili-Miner M (1999) Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med 27:1794–1799PubMed

13.

Garnacho-Montero J, Ortiz-Leyba C, Jiménez-Jiménez FJ, Barrero-Almodóvar AE, García-Garmendia JL, Bernabeu-Wittel M, Gallego-Lara (2003) Treatment of multiresistant Acinetobacter baumannii ventilator-associated pneumonia with intravenous colistin: a comparison with imipenem susceptible episodes. Clin Infect Dis (in press)

14.

Corbella X, Ariza J, Ardanuy C, Vuelta M, Tubau F, Sora M, Pujol M, Gudiol F (1998) Efficacy of sulbactam alone and in association with ampicillin in nosocomial infections due to Acinetobacter baumannii. J Antimicrob Chemother 42:793–802CrossRef

15.

Gerner-Smidt P (1987) Endemic occurrence of Acinetobacter calcoaceticus biovar anitratus in an intensive care unit. J Hosp Infect 10:265–272PubMed

Title: Acinetobacter baumannii: a threat for the ICU?
Authors: Jordi Rello
Emili Diaz
Publication date: 01-03-2003
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 3/2003
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-003-1661-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Acinetobacter baumannii: a threat for the ICU?

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2003

Irreversible ischemia of the hand after peripheral administration of tromethamol (THAM)

Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study

Heart enlargement after thrombolysis for unsuccessful resuscitation

Obtaining consent for research studies on incompetent subjects: the Quebec experience

Impact of pulmonary artery occlusion pressure value on the definition of acute respiratory distress syndrome

Fatal hemorrhage due to an isolated dissection of the superior mesenteric artery